Regen BioPharma, Inc. RGBPP
RGBPP
Regen BioPharma, Inc. NMLSF
Restart Life Sciences Corp. RNUGF
ReNeuron Group plc APLIF
Appili Therapeutics Inc. ADXS
Ayala Pharmaceuticals, Inc. AGNPF
Algernon Pharmaceuticals Inc. ZLDAF
Zelira Therapeutics Limited PKTX
ProtoKinetix, Incorporated IBOGF
Universal Ibogaine Inc. HAVLF
HAVN Life Sciences Inc.
Regen BioPharma, Inc. NMLSF
Restart Life Sciences Corp. RNUGF
ReNeuron Group plc APLIF
Appili Therapeutics Inc. ADXS
Ayala Pharmaceuticals, Inc. AGNPF
Algernon Pharmaceuticals Inc. ZLDAF
Zelira Therapeutics Limited PKTX
ProtoKinetix, Incorporated IBOGF
Universal Ibogaine Inc. HAVLF
HAVN Life Sciences Inc.
Performance
| Periode | RGBPP | NMLSF | RNUGF | APLIF | ADXS | AGNPF | ZLDAF | PKTX | IBOGF | HAVLF |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -16.19 % | 100.13 % | 0.00 % | 35.45 % | 320.42 % | 9.12 % | -16.39 % | -23.86 % | -65.78 % | 280.00 % |
| YTD | -15.14 % | 215.00 % | 0.00 % | -39.68 % | 418.52 % | 34.34 % | -39.05 % | -32.73 % | -49.29 % | 90.00 % |
| 1Y | -39.36 % | 164.56 % | 0.00 % | -42.69 % | 418.52 % | 32.34 % | -34.20 % | -31.77 % | -49.29 % | 90.00 % |
| 3Y | -99.54 % | -87.16 % | -98.90 % | -42.91 % | -87.04 % | -85.28 % | -65.41 % | -79.70 % | -61.62 % | -95.00 % |
| 5Y | -95.14 % | -95.28 % | -99.89 % | -98.26 % | -99.52 % | -98.65 % | -98.33 % | -92.95 % | -92.50 % | -99.99 % |
| 10Y | -99.89 % | -90.32 % | -99.98 % | -98.88 % | -100.00 % | -99.64 % | -96.67 % | -88.83 % | -92.50 % | -99.99 % |
| From the beginning | -99.89 % | -99.77 % | -100.00 % | -98.88 % | -100.00 % | -99.64 % | -96.67 % | -98.40 % | -92.50 % | -99.99 % |